DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,793,686 | +38.3% | 76,365 | +51.0% | 0.05% | +45.5% |
| Q2 2023 | $12,140,400 | +98.2% | 50,585 | +108.1% | 0.03% | +73.7% |
| Q1 2023 | $6,126,336 | +87909.4% | 24,307 | -7.3% | 0.02% | -34.5% |
| Q4 2022 | $6,961 | -100.0% | 26,224 | -90.9% | 0.03% | -77.5% |
| Q2 2022 | $74,520,000 | +3487.9% | 288,828 | +4478.0% | 0.13% | +2480.0% |
| Q4 2021 | $2,077,000 | -12.5% | 6,309 | -19.6% | 0.01% | -16.7% |
| Q3 2021 | $2,374,000 | +180.0% | 7,850 | +148.6% | 0.01% | +200.0% |
| Q2 2021 | $848,000 | -91.4% | 3,158 | -92.8% | 0.00% | -90.9% |
| Q1 2021 | $9,909,000 | -35.4% | 44,003 | -36.3% | 0.02% | -15.4% |
| Q4 2020 | $15,349,000 | -62.7% | 69,084 | -63.8% | 0.03% | -71.4% |
| Q3 2020 | $41,162,000 | +40.9% | 190,989 | +15.6% | 0.09% | -10.8% |
| Q2 2020 | $29,222,000 | +10449.5% | 165,285 | +8164.2% | 0.10% | +10100.0% |
| Q1 2020 | $277,000 | -84.7% | 2,000 | -83.1% | 0.00% | -85.7% |
| Q4 2019 | $1,814,000 | -94.1% | 11,815 | -94.5% | 0.01% | -93.9% |
| Q3 2019 | $30,520,000 | +429.3% | 214,900 | +436.9% | 0.12% | +784.6% |
| Q2 2019 | $5,766,000 | -23.6% | 40,024 | -45.4% | 0.01% | -53.6% |
| Q4 2018 | $7,547,000 | -5.9% | 73,265 | -0.1% | 0.03% | 0.0% |
| Q3 2018 | $8,016,000 | +647.8% | 73,366 | +575.1% | 0.03% | +833.3% |
| Q2 2018 | $1,072,000 | -93.1% | 10,867 | -93.3% | 0.00% | -66.7% |
| Q1 2018 | $15,579,000 | +248.0% | 161,714 | +235.3% | 0.01% | +12.5% |
| Q4 2017 | $4,477,000 | +44.2% | 48,234 | +33.1% | 0.01% | +14.3% |
| Q3 2017 | $3,105,000 | -29.5% | 36,235 | -30.5% | 0.01% | -36.4% |
| Q2 2017 | $4,403,000 | +885.0% | 52,160 | +900.4% | 0.01% | +1000.0% |
| Q1 2017 | $447,000 | -88.0% | 5,214 | -89.1% | 0.00% | -88.9% |
| Q4 2016 | $3,717,000 | -82.4% | 47,703 | -82.3% | 0.01% | -84.7% |
| Q3 2016 | $21,114,000 | -23.7% | 270,000 | -2.0% | 0.06% | -35.2% |
| Q2 2016 | $27,686,000 | +65.6% | 275,377 | +56.4% | 0.09% | +62.5% |
| Q1 2016 | $16,716,000 | +4017.2% | 176,063 | +3932.6% | 0.06% | +5500.0% |
| Q4 2015 | $406,000 | -65.2% | 4,366 | -68.3% | 0.00% | -75.0% |
| Q3 2015 | $1,168,000 | -93.8% | 13,786 | -93.8% | 0.00% | -92.5% |
| Q2 2015 | $18,871,000 | +24.8% | 221,945 | +23.9% | 0.05% | +8.2% |
| Q1 2015 | $15,126,000 | -58.6% | 179,114 | -58.2% | 0.05% | -50.0% |
| Q4 2014 | $36,507,000 | -43.6% | 428,389 | -49.6% | 0.10% | -44.0% |
| Q3 2014 | $64,691,000 | -13.7% | 849,240 | -10.9% | 0.18% | +733.3% |
| Q2 2014 | $75,004,000 | +577.4% | 953,165 | +545.0% | 0.02% | +600.0% |
| Q1 2014 | $11,072,000 | +49.7% | 147,778 | +54.2% | 0.00% | -91.2% |
| Q4 2013 | $7,394,000 | +12.9% | 95,838 | +1.5% | 0.03% | -12.8% |
| Q3 2013 | $6,549,000 | +113.8% | 94,445 | +95.0% | 0.04% | +56.0% |
| Q2 2013 | $3,063,000 | -76.4% | 48,424 | -76.8% | 0.02% | -81.8% |
| Q1 2013 | $12,975,000 | +170.2% | 209,070 | +143.1% | 0.14% | +158.5% |
| Q4 2012 | $4,802,000 | – | 86,014 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |